会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Signaling inositol polyphosphate 5-phosphatases (SIPs)
    • 信号多聚磷酸肌醇5磷酸酶(SIPs)
    • US6090621A
    • 2000-07-18
    • US195868
    • 1998-11-19
    • W. Michael KavanaughDavid PotLewis T. Williams
    • W. Michael KavanaughDavid PotLewis T. Williams
    • A61K38/00C07K16/40C12N9/16C12N15/55C12N5/06
    • C12N9/16C07K16/40A61K38/00
    • Novel polypeptides called signaling inositol polyphosphate 5-phosphatases are described called SIP-130, SIP-125, and SIP-N. SIP-130 is capable of binding to aPTB domain of SH2 and collagen containing protein (SHC). Also provided are polynucleotide sequences encoding the novel polypeptides, as well as vectors and host cells containing the polynucleotides. Further provided are modulators including agonists and antagonists of the novel polypeptides for use as therapeutics, including antibodies, polypeptides, small molecules, and polynucleotides and methods of using the therapeutics in treatment of diseases associated with abnormal cell growth. Methods of making the polypeptides, polynucleotides, vectors, host cells, antibodies, and small molecules are also provided. Gene delivery vehicles including SIP and SIP activity-modulating polynucleotides are described.
    • 称为信号多聚磷酸肌醇5磷酸酶的新型多肽被称为SIP-130,SIP-125和SIP-N。 SIP-130能够结合到SH2和含胶原蛋白(SHC)的aPTB结构域。 还提供了编码新多肽的多核苷酸序列以及含有多核苷酸的载体和宿主细胞。 还提供了包括用作治疗剂的新型多肽的激动剂和拮抗剂的调节剂,包括抗体,多肽,小分子和多核苷酸以及使用治疗剂治疗与异常细胞生长有关的疾病的方法。 还提供了制备多肽,多核苷酸,载体,宿主细胞,抗体和小分子的方法。 描述了包括SIP和SIP活性调节多核苷酸的基因递送载体。